371 related articles for article (PubMed ID: 3109864)
81. Candida maltosa NADPH-cytochrome P450 reductase: cloning of a full-length cDNA, heterologous expression in Saccharomyces cerevisiae and function of the N-terminal region for membrane anchoring and proliferation of the endoplasmic reticulum.
Kärgel E; Menzel R; Honeck H; Vogel F; Böhmer A; Schunck WH
Yeast; 1996 Mar; 12(4):333-48. PubMed ID: 8701606
[TBL] [Abstract][Full Text] [Related]
82. Functional co-expression of human oxidoreductase and cytochrome P450 1A1 in Saccharomyces cerevisiae results in increased EROD activity.
Eugster HP; Bärtsch S; Würgler FE; Sengstag C
Biochem Biophys Res Commun; 1992 Jun; 185(2):641-7. PubMed ID: 1610357
[TBL] [Abstract][Full Text] [Related]
83. Purification, cDNA cloning and functional expression of NADPH-cytochrome P450 reductase from Centaurium erythraea cell cultures.
Schwarz H; Liu B; Peters S; Barillas W; Beerhues L
Plant Biol (Stuttg); 2009 May; 11(3):300-6. PubMed ID: 19470102
[TBL] [Abstract][Full Text] [Related]
84. Molecular cloning and functional characterization of NADPH-dependent cytochrome P450 reductase from the green microalga Botryococcus braunii, B race.
Tsou CY; Matsunaga S; Okada S
J Biosci Bioeng; 2018 Jan; 125(1):30-37. PubMed ID: 28818427
[TBL] [Abstract][Full Text] [Related]
85. Co-incorporation of heterologously expressed Arabidopsis cytochrome P450 and P450 reductase into soluble nanoscale lipid bilayers.
Duan H; Civjan NR; Sligar SG; Schuler MA
Arch Biochem Biophys; 2004 Apr; 424(2):141-53. PubMed ID: 15047186
[TBL] [Abstract][Full Text] [Related]
86. Co-expression of recombinant human CYP2C9 with human cytochrome P450 reductase in protease deficient S. cerevisiae strain at a higher scale yields an enzyme of higher specific activity.
Rao KN; Suman SK; Kiran YR; Kuanr AR; Gupta AK; Bhalla K; Kumar V; Kundu P; Arora K; Soni R
Drug Metab Lett; 2010 Dec; 4(4):246-53. PubMed ID: 20722625
[TBL] [Abstract][Full Text] [Related]
87. The omega-hydroxlyation of lauric acid: oxidation of 12-hydroxlauric acid to dodecanedioic acid by a purified recombinant fusion protein containing P450 4A1 and NADPH-P450 reductase.
Shet Ms; Fisher CW; Holmans PL; Estabrook RW
Arch Biochem Biophys; 1996 Jun; 330(1):199-208. PubMed ID: 8651697
[TBL] [Abstract][Full Text] [Related]
88. Complexation of membrane-bound enzyme systems.
Müller-Enoch D; Gruler H
Z Naturforsch C J Biosci; 2000; 55(9-10):747-52. PubMed ID: 11098825
[TBL] [Abstract][Full Text] [Related]
89. Reconstitution of the brain mixed function oxidase system: purification of NADPH-cytochrome P450 reductase and partial purification of cytochrome P450 from whole rat brain.
Bergh AF; Strobel HW
J Neurochem; 1992 Aug; 59(2):575-81. PubMed ID: 1629729
[TBL] [Abstract][Full Text] [Related]
90. High promutagen activating capacity of yeast microsomes containing human cytochrome P-450 1A and human NADPH-cytochrome P-450 reductase.
Sengstag C; Eugster HP; Würgler FE
Carcinogenesis; 1994 May; 15(5):837-43. PubMed ID: 8200084
[TBL] [Abstract][Full Text] [Related]
91. Partial recoding of P450 and P450 reductase cDNAs for improved expression in yeast and plants.
Hehn A; Morant M; Werck-Reichhart D
Methods Enzymol; 2002; 357():343-51. PubMed ID: 12424924
[No Abstract] [Full Text] [Related]
92. Rat brain NADPH-dependent diaphorase. A possible relationship to cytochrome P450 reductase.
Kemp MC; Kuonen DR; Sutton A; Roberts PJ
Biochem Pharmacol; 1988 Aug; 37(16):3063-70. PubMed ID: 3135810
[TBL] [Abstract][Full Text] [Related]
93. Establishment of a yeast system that stably expresses human cytochrome P450 reductase: application for the study of drug metabolism of cytochrome P450s in vitro.
Cheng J; Wan DF; Gu JR; Gong Y; Yang SL; Hao DC; Yang L
Protein Expr Purif; 2006 Jun; 47(2):467-76. PubMed ID: 16434211
[TBL] [Abstract][Full Text] [Related]
94. New platform for cytochrome p450 reaction combining in situ immobilization on biopolymer.
Lee JH; Nam DH; Lee SH; Park JH; Park SJ; Lee SH; Park CB; Jeong KJ
Bioconjug Chem; 2014 Dec; 25(12):2101-4. PubMed ID: 25322062
[TBL] [Abstract][Full Text] [Related]
95. Enhanced in vivo monooxygenase activities of mammalian P450s in engineered yeast cells producing high levels of NADPH-P450 reductase and human cytochrome b5.
Truan G; Cullin C; Reisdorf P; Urban P; Pompon D
Gene; 1993 Mar; 125(1):49-55. PubMed ID: 8449412
[TBL] [Abstract][Full Text] [Related]
96. Molecular cloning of NADPH-cytochrome P450 oxidoreductase from silkworm eggs. Its involvement in 20-hydroxyecdysone biosynthesis during embryonic development.
Horike N; Takemori H; Nonaka Y; Sonobe H; Okamoto M
Eur J Biochem; 2000 Dec; 267(23):6914-20. PubMed ID: 11082204
[TBL] [Abstract][Full Text] [Related]
97. The expression of human cytochrome P450IA1 in the yeast Saccharomyces cerevisiae.
Ching MS; Lennard MS; Tucker GT; Woods HF; Kelly DE; Kelly SL
Biochem Pharmacol; 1991 Jul; 42(4):753-8. PubMed ID: 1867632
[TBL] [Abstract][Full Text] [Related]
98. Kinetic and structural properties of biocatalytically active sheep lung microsomal NADPH-cytochrome c reductase.
Işcan MY; Arinç E
Int J Biochem; 1986; 18(8):731-41. PubMed ID: 3091421
[TBL] [Abstract][Full Text] [Related]
99. Expression of a functional 78,000 dalton mammalian flavoprotein, NADPH-cytochrome P-450 oxidoreductase, in Escherichia coli.
Porter TD; Wilson TE; Kasper CB
Arch Biochem Biophys; 1987 Apr; 254(1):353-67. PubMed ID: 3107472
[TBL] [Abstract][Full Text] [Related]
100. Characterization of superoxide dismutase-insensitive cytochrome c reductase activity in HL-60 cytosol as NADPH-cytochrome P450 reductase.
Nisimoto Y; Otsuka-Murakami H; Iwata S; Isogai Y; Iizuka T
Arch Biochem Biophys; 1993 May; 302(2):315-21. PubMed ID: 8489236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
